Dr. Jeanna L Knoble
Claim this profileZangmeister Cancer Center
Studies Breast Cancer
Studies Cancer
3 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
Stage III
2Cancer
Stage III
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Jeanna L Knoble is currently running
Tucatinib + Trastuzumab + Pertuzumab
for Breast Cancer
This study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast cancer. A placebo is a pill that looks the same as tucatinib but has no medicine in it. This study will also test what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants will have cancer that has spread in the body near where it started (locally advanced) and cannot be removed (unresectable) or has spread through the body (metastatic). In this study, all participants will get either tucatinib or placebo. Participants will be assigned randomly to a group. This is a blinded study, so patients and their doctors will not know which group a participant is in. All participants will also get trastuzumab and pertuzumab. These are 2 drugs used to treat this type of cancer.
Recruiting1 award Phase 311 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
More about Jeanna L Knoble
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jeanna L Knoble has experience with
- Imlunestrant
- Exemestane
- Tucatinib
- Trastuzumab
- Pertuzumab
- Placebo
Breakdown of trials Jeanna L Knoble has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeanna L Knoble specialize in?
Jeanna L Knoble focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Jeanna L Knoble currently recruiting for clinical trials?
Yes, Jeanna L Knoble is currently recruiting for 3 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Jeanna L Knoble has studied deeply?
Yes, Jeanna L Knoble has studied treatments such as Imlunestrant, Exemestane, Tucatinib.
What is the best way to schedule an appointment with Jeanna L Knoble?
Apply for one of the trials that Jeanna L Knoble is conducting.
What is the office address of Jeanna L Knoble?
The office of Jeanna L Knoble is located at: Zangmeister Cancer Center, Columbus, Ohio 43219 United States. This is the address for their practice at the Zangmeister Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.